Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. and covers a range of therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators and vaccine adjuvants. SafeCoat Medical Inc.'s technology incorporates self-assembling biocompatible polymers combined with conjugated antimicrobial peptides.


CSE:ASEP - Post by User

User Avatar Image
(273)
•••
  • partystockerX
Post by partystockeron Apr 11, 2022 10:29am
142 Views
Post# 34593503

$ASEP.c's Market Opportunity Is Large

$ASEP.c's Market Opportunity Is Large

This report from RTI really solidifies Asep Medical’s (CSE: ASEP) market opportunity as a developer of novel sepsis diagnostic and therapeutic solutions. 


Given the prevalence of sepsis, the report reveals improved treatment and diagnostic solutions could result in an overall savings of up to $22 billion annually in the US alone.


$ASEP.c is currently performing formal studies for its Sepset diagnostic solution and is expecting to file a 510(k) application in the latter half of 2022. I’m highly anticipating updates on this as a big catalyst. 


$ASEP.c is currently trading at $.35 and is valued at $19.65M. 


https://ca.finance.yahoo.com/news/asep-medical-holdings-inc-announces-120000639.html

 
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities